Opioids and their receptors: Are we there yet?

Neuropharmacology

Volumn 76, Issue PART B, 2014, Pages 198-203

  Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

G protein coupled receptor; MOR 1; Morphine; Mu receptor; Opioid receptor; Splice variant; Truncated

Indexed keywords

3 IODOBENZOYL 6BETA NALTREXAMIDE; G PROTEIN COUPLED RECEPTOR; MOR 1 PROTEIN; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; OPIATE; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

GENETIC VARIABILITY; HUMAN; MOLECULAR CLONING; MU OPIOID RECEPTOR GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

G-PROTEIN COUPLED RECEPTOR; MOR-1; MORPHINE; MU RECEPTOR; OPIOID RECEPTOR; SPLICE VARIANT; TRUNCATED;

ANALGESICS, OPIOID; ANIMALS; HUMANS; RECEPTORS, OPIOID;

EID: 84887080687     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.03.039     Document Type: Review

References (94)

1. C. Abbadie, S.H. Gultekin, and G.W. Pasternak Immunohistochemical localization of the carboxy terminus of the novel mu opioid receptor splice variant MOR-1C within the human spinal cord Neuroreport 11 2000 1953 1957 (Pubitemid 30429142)
2. C. Abbadie, Y.-X. Pan, C.T. Drake, and G.W. Pasternak Comparative immunhistochemical distributions of carboxy terminus epitopes from the mu opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat central nervous systems Neuroscience 100 2000 141 153 (Pubitemid 30670308)
3. C. Abbadie, Y.-X. Pan, and G.W. Pasternak Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C and MOR-1-like immunoreactivity: evidence for region-specific processing J.Comp.Neurol. 419 2000 244 256 (Pubitemid 30133505)
4. C. Abbadie, Y.-X. Pan, and G.W. Pasternak Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in the mouse brain Neuroscience i 2004 419 430 (Pubitemid 38950657)
5. C. Abbadie, and G.W. Pasternak Differential in vivo internalization of MOR-1 and MOR-1C by morphine Neuroreport 12 2001 3069 3072 (Pubitemid 32907006)
6. C. Abbadie, G.W. Pasternak, and S.A. Aicher Presynaptic localization of the carboxy-terminus epitopes of the mu opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord Neuroscience 106 2001 833 842 (Pubitemid 33000187)
7. L.A. Bare, E. Mansson, and D. Yang Expression of two variants of the human μ opioid receptor mRNA in SK-N-SH cells and human brain FEBS Lett. 354 1994 213 216 (Pubitemid 24335510)
8. A.H. Beckett, and A.F. Casy Analgesics and their antagonists: biochemical aspects and structure-activity relationships Prog.Med.Chem. 4 1965 171 218
9. I. Berezniuk, and L.D. Fricker Endogenous Opioids second ed. 2011 93 120
10. E.A. Bolan, G.W. Pasternak, and Y.-X. Pan Functional analysis of MOR-1 splice variants of the mu opioid receptor gene, Oprm Synapse 51 2004 11 18 (Pubitemid 37421135)
11. J.R. Bunzow, C. Saez, M. Mortrud, C. Bouvier, J.T. Williams, M. Low, and D.K. Grandy Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or kappa opioid receptor type FEBS Lett. 347 1994 284 288 (Pubitemid 24215413)
12. P. Cadet, K.J. Mantione, and G.B. Stefano Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene J. Immunol. 170 2003 5118 5123 (Pubitemid 36554743)
13. C. Chavkin, and A. Goldstein Specific receptor for the opioid peptide dynorphin: structure-activity relationships Proc. Natl. Acad. Sci. U. S. A. 78 1981 6543 6547 (Pubitemid 12208179)
14. Y. Chen, Y. Fan, J. Liu, A. Mestek, M. Tian, C.A. Kozak, and L. Yu Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family FEBS Lett. 347 1994 279 283 (Pubitemid 24215412)
15. Y. Chen, A. Mestek, J. Liu, J.A. Hurley, and L. Yu Molecular cloning and functional expression of a μ-opioid receptor from rat brain Mol. Pharmacol. 44 1993 8 12 (Pubitemid 23230453)
16. H.S. Choi, C.S. Kim, C.K. Hwang, K.Y. Song, W. Wang, Y. Qiu, P.Y. Law, L.N. Wei, and H.H. Loh The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor Biochem. Biophys. Res. Commun. 343 2006 1132 1140
17. G.A. Doyle, X. Rebecca Sheng, S.S. Lin, D.M. Press, D.E. Grice, R.J. Buono, T.N. Ferraro, and W.H. Berrettini Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon Gene 388 2007 135 147 (Pubitemid 46014022)
18. G.A. Doyle, X.R. Sheng, C.L. Schwebel, T.N. Ferraro, W.H. Berrettini, and R.J. Buono Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice Neurosci. Res. 55 2006 244 254 (Pubitemid 43766415)
19. N.B. Eddy The National Research Council Involvement in the Opiate Problem, 1928-1971 1973
20. C.M. Eppler, J.D. Hulmes, J.-B. Wang, B. Johnson, M. Corbett, D.R. Luthin, G.R. Uhl, and J. Linden Purification and partial amino acid sequence of a μ opioid receptor from rat brain J. Biol. Chem. 268 1993 26447 26451 (Pubitemid 23361722)
21. C.J. Evans, D.E. Keith Jr., H. Morrison, K. Magendzo, and R.H. Edwards Cloning of a delta opioid receptor by functional expression Science 258 1992 1952 1955
22. K.M. Foley The treatment of cancer pain N. Engl. J. Med. 313 1985 84 95 (Pubitemid 15068702)
23. K.M. Foley Controlling the pain of cancer Sci. Am. 275 1996 164 165
24. K. Fukuda, S. Kato, K. Mori, M. Nishi, H. Takeshima, N. Iwabe, T. Miyata, T. Houtani, and T. Siguimoti cDNA cloning and regional distribution of a novel member of the opioid receptor family FEBS Lett. 343 1994 42 46 (Pubitemid 24123943)
25. A. Goldstein, L.I. Lowney, and B.K. Pal Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain Proc. Natl. Acad. Sci. U. S. A. 68 1971 1742 1747
26. A. Goldstein, S. Tachibana, L.I. Lowney, M. Hunkapiller, and L. Hood Dynorphin-(1-13), an extraordinarily potent opioid peptide Proc. Natl. Acad. Sci. U. S. A. 76 1979 6666 6670 (Pubitemid 10166229)
27. J.S. Heyman, C.L. Williams, T.F. Burks, H.I. Mosberg, and F. Porreca Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine J. Pharmacol. Exp. Ther. 245 1988 238 243
28. R.W. Houde, and S.L. Wallenstein Clinical studies of morphine-nalorphine combinations Fed. Proc. 15 1956 440 441
29. J. Hughes Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine Brain Res. 88 1975 295 308
30. J. Hughes, T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan, and H.R. Morris Identification of two related pentapeptides from the brain with potent opiate agonist activity Nature 258 1975 577 579
31. D. Keith Jr., T. Maung, B. Anton, and C. Evans Isolation of cDNA clones homologous to opioid receptors Regul. Pept. 54 1994 143 144 (Pubitemid 24360372)
32. D.E. Keith, B. Anton, S.R. Murray, P.A. Zaki, P.C. Chu, D.V. Lissin, G. Monteillet-Agius, P.L. Stewart, C.J. Evans, and M. Von Zastrow μ-opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain Mol. Pharmacol. 53 1998 377 384 (Pubitemid 28162857)
33. D.E. Keith, S.R. Murray, P.A. Zaki, P.C. Chu, D.V. Lissin, L. Kang, C.J. Evans, and M. Von Zastrow Morphine activates opioid receptors without causing their rapid internalization J. Biol. Chem. 271 1996 19021 19024 (Pubitemid 26271556)
34. B.L. Kieffer, K. Befort, C. Gaveriaux-Ruff, and C.G. Hirth The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization Proc. Natl. Acad. Sci. U. S. A. 89 1992 12048 12052 (Pubitemid 23004782)
35. L. Lasagna, and H.K. Beecher The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man J. Pharmacol. Exp. Ther. 112 1954 356 363
36. C.H. Li, D. Chung, and B.A. Doneen Isolation, characterization and opiate activity of beta-endorphin from human pituitary glands Biochem. Biophys. Res. Commun. 72 1976 1542 1547
37. G.S.F. Ling, J.M. MacLeod, S. Lee, S.H. Lockhart, and G.W. Pasternak Separation of morphine analgesia from physical dependence Science 226 1984 462 464 (Pubitemid 14012817)
38. G.S.F. Ling, and G.W. Pasternak Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites Brain Res. 271 1983 152 156 (Pubitemid 13071025)
39. G.S.F. Ling, R. Simantov, J.A. Clark, and G.W. Pasternak Naloxonazine actions in vivo Eur. J. Pharmacol. 129 1986 33 38 (Pubitemid 16033004)
40. G.S.F. Ling, K. Spiegel, S.H. Lockhart, and G.W. Pasternak Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms J. Pharmacol. Exp. Ther. 232 1985 149 155 (Pubitemid 15193665)
41. G.S.F. Ling, K. Spiegel, S. Nishimura, and G.W. Pasternak Dissociation of morphine's analgesic and respiratory depressant actions Eur. J. Pharmacol. 86 1983 487 488 (Pubitemid 13171535)
42. W. Liu, E. Chun, A. Thompson, and P. Chubukov Structural basis for allosteric regulation of GPCRs by sodium ions Science 337 2012 232 236
43. H.H. Loh, H.C. Liu, A. Cavalli, W.L. Yang, Y.F. Chen, and L.N. Wei μ opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality Mol. Brain Res. 54 1998 321 326 (Pubitemid 28171797)
44. J.A.H. Lord, A.A. Waterfield, J. Hughes, and H.W. Kosterlitz Multiple Opiate Receptors. Opiates and Endogenous Opioid Peptides 1976 275 280
45. J.A.H. Lord, A.A. Waterfield, J. Hughes, and H.W. Kosterlitz Endogenous opioid peptides: multiple agonists and receptors Nature 267 1977 495 499 (Pubitemid 8098466)
46. 1: a very high affinity subtype of enkephalin binding sites in rat brain Life Sci. 36 1985 2233 2338
47. S. Majumdar, S. Grinnell, V. Le Rouzic, M. Burgman, L. Polikar, M. Ansonoff, J. Pintar, Y.X. Pan, and G.W. Pasternak Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects Proc. Natl. Acad. Sci. U. S. A. 108 2011 19776 19783
48. S. Majumdar, J. Subrath, V. Le Rouzic, L. Polikar, M. Burgman, K. Nagakura, J. Ocampo, N. Haselton, A.R. Pasternak, S. Grinnell, Y.-X. Pan, and G.W. Pasternak Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated mu opioid receptor (MOR-1) splice variants J. Med. Chem. 55 2012 6352 6362
49. W.R. Martin Opioid antagonists Pharmacol. Rev. 19 1967 463 521
50. W.R. Martin, C.G. Eades, J.A. Thompson, R.E. Huppler, and P.E. Gilbert The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog J. Pharmacol. Exp. Ther. 197 1976 517 532
51. H.W.D. Matthes, R. Maldonado, F. Simonin, O. Valverde, S. Slowe, I. Kitchen, K. Befort, A. Dierich, M. Le Meur, P. Dollé, E. Tzavara, J. Hanoune, B.P. Roques, and B.L. Kieffer Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene Nature 383 1996 819 823
52. 1 receptor Nature 377 1995 532 535
53. C. Mollereau, M. Parmentier, P. Mailleux, J.L. Butour, C. Moisand, P. Chalon, D. Caput, G. Vassart, and J.C. Meunier ORL-1, a novel member of the opioid family: cloning, functional expression and localization FEBS Lett. 341 1994 33 38
54. P.J. Munson, R.A. Cruciani, R.A. Lutz, and D. Rodbard New methods for characterization of complex receptor systems involving 3 or more binding sites: application to brain opiate receptors J. Recept. Res. 4 1984 339 355 (Pubitemid 15190370)
55. L. Pan, J. Xu, R. Yu, M.M. Xu, Y.X. Pan, and G.W. Pasternak Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene Oprm. Neurosci. 133 2005 209 220 (Pubitemid 40694171)
56. Y.-X. Pan, J.Y. Xu, M.M. Xu, R. Yu, E. Bolan, A.K. Gilbert, and G.W. Pasternak Isolation and expression of three new splice variants, mMOR-1A, mMOR-1O and mMOR-1P, from mouse mu opioid receptor gene Oprm 2009 submitted for publication
57. Y.X. Pan Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters DNA Cell. Biol. 24 2005 736 750
58. Y.X. Pan, J. Xu, E. Bolan, A. Chang, L. Mahurter, G. Rossi, and G.W. Pasternak Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F FEBS Lett. 466 2000 337 340 (Pubitemid 30069853)
59. Y.X. Pan, J. Xu, E. Bolan, H.S. Moskowitz, M. Xu, and G.W. Pasternak Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing Mol. Pharmacol. 68 2005 866 875 (Pubitemid 41206043)
60. Y.X. Pan, J. Xu, E.A. Bolan, C. Abbadie, A. Chang, A. Zuckerman, G.C. Rossi, and G.W. Pasternak Identification and characterization of three new alternatively spliced mu opioid receptor isoforms Mol. Pharmacol. 56 1999 396 403 (Pubitemid 29347617)
61. Y.X. Pan, J. Xu, L. Mahurter, M. Xu, A.K. Gilbert, and G.W. Pasternak Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X Biochem. Biophys. Res. Commun. 301 2003 1057 1061 (Pubitemid 36279220)
62. Y.X. Pan, J. Xu, M. Xu, G.C. Rossi, J.E. Matulonis, and G.W. Pasternak Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions Proc. Natl. Acad. Sci. U. S. A. 106 2009 4917 4922
63. Y.-X. Pan Identification and characterization of a novel promoter of a mouse mu opioid receptor gene (Oprm) that generates eight splice variants Gene 295 2000 97 108 (Pubitemid 35283821)
64. 3-related opioid receptor using antisense oligodeoxynucleotides Regul. Pept. 54 1994 217 218 (Pubitemid 24360409)
65. Y.-X. Pan, J. Xu, L. Mahurter, E.A. Bolan, M.M. Xu, and G.W. Pasternak Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene Proc. Natl. Acad. Sci. U. S. A. 98 2001 14084 14089 (Pubitemid 33116028)
66. D.A. Pasternak, L. Pan, J. Xu, R. Yu, M.M. Xu, G.W. Pasternak, and Y.X. Pan Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy J. Neurochem. 91 2004 881 890 (Pubitemid 39507365)
67. G.W. Pasternak, R. Goodman, and S.H. Snyder An endogenous morphine like factor in mammalian brain Life Sci. 16 1975 1765 1769
68. G.W. Pasternak, and Y.-X. Pan Mu opioids and their receptors: evolution of a concept Pharmacol. Rev. 2013 in press
69. 3H]opiate agonist binding by divalent cations Mol. Pharmacol. 11 1975 478 484
70. G.W. Pasternak, and S.H. Snyder Identification of a novel high affinity opiate receptor binding in rat brain Nature 253 1975 563 565
71. G.W. Pasternak, and S.H. Snyder Opiate receptor binding: enzymatic treatments and discrimination between agonists and antagonists Mol. Pharmacol. 11 1975 735 744
72. G.W. Pasternak, H.A. Wilson, and S.H. Snyder Differential effects of protein-modifying reagants on receptor binding of opiate agonists and antagonists Mol. Pharmacol. 11 1975 340 351
73. D. Paul, R.J. Bodnar, M.A. Gistrak, and G.W. Pasternak Different μ receptor subtypes mediate spinal and supraspinal analgesia in mice Eur. J. Pharmacol. 168 1989 307 314 (Pubitemid 19231507)
74. D. Paul, and G.W. Pasternak Differential blockade by naloxonazine of two μ opiate actions: analgesia and inhibition of gastrointestinal transit Eur. J. Pharmacol. 149 1988 403 404
75. R. Payne, and G.W. Pasternak Pain 1992 268 301
76. C.B. Pert, G.W. Pasternak, and S.H. Snyder Opiate agonists and antagonists discriminated by receptor binding in brain Science 182 1973 1359 1361
77. P.S. Portoghese A new concept on the mode of interaction of narcotic analgesics with receptors J. Med. Chem. 8 1965 609 616
78. P.S. Portoghese Stereochemical factors and receptor interactions associated with narcotic analgesics J. Pharm. Sci. 55 1966 865 887
79. K.M. Raehal, C.L. Schmid, C.E. Groer, and L.M. Bohn Functional selectivity at the mu-opioid receptor: implications for understanding opioid analgesia and tolerance Pharmacol. Rev. 63 2011 1001 1019
80. R.K. Reinscheid, H.P. Nothacker, A. Bourson, A. Ardati, R.A. Henningsen, J.R. Bunzow, D.K. Grandy, H. Langen, F.J. Monsma, and O. Civelli Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor Science 270 1995 792 794
81. A.G. Schuller, M.A. King, J. Zhang, E. Bolan, Y.X. Pan, D.J. Morgan, A. Chang, M.E. Czick, E.M. Unterwald, G.W. Pasternak, and J.E. Pintar Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1 Nat. Neurosci. 2 1999 151 156 (Pubitemid 30491315)
82. S.A. Shabalina, D.V. Zaykin, P. Gris, A.Y. Ogurtsov, J. Gauthier, K. Shibata, I.E. Tchivileva, I. Belfer, B. Mishra, C. Kiselycznyk, M.R. Wallace, R. Staud, N.A. Spiridonov, M.B. Max, D. Goldman, R.B. Fillingim, W. Maixner, and L. Diatchenko Expansion of the human mu-opioid receptor gene architecture: novel functional variants Hum. Mol. Genet. 18 2009 1037 1051
83. 3H]etorphine to rat-brain homogenate Proc. Natl. Acad. Sci. U. S. A. 70 1973 1947 1949
84. I. Sora, N. Takahashi, M. Funada, H. Ujike, R.S. Revay, D.M. Donovan, L.L. Miner, and G.R. Uhl Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia Proc. Natl. Acad. Sci. U. S. A. 94 1997 1544 1549 (Pubitemid 27087888)
85. K. Spiegel, I. Kourides, and G.W. Pasternak Prolactin and growth hormone release by morphine in the rat: different receptor mechanisms Science 217 1982 745 747 (Pubitemid 12049579)
86. L. Terenius Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex Acta Pharmacol. et toxicol. 32 1973 317 320
87. L. Terenius, and A. Wahlstrom Search for an endogenous ligand for the opiate receptor Acta Physiol. Scand. 94 1975 74 81
88. R.C. Thompson, A. Mansour, H. Akil, and S.J. Watson Cloning and pharmacological characterization of a rat μ opioid receptor Neuron 11 1993 903 913 (Pubitemid 23347475)
89. J.B. Wang, Y. Imai, C.M. Eppler, P. Gregor, C.E. Spivak, and G.R. Uhl μ opiate receptor: cDNA cloning and expression Proc. Natl. Acad. Sci. U. S. A. 90 1993 10230 10234 (Pubitemid 23328286)
90. H.A. Wilson, G.W. Pasternak, and S.H. Snyder Differentiation of opiate agonist and antagonist receptor binding by protein-modifying reagants Nature 256 1975 448 450
91. B.L. Wolozin, and G.W. Pasternak Classification of multiple morphine and enkephalin binding sites in the central nervous system Proc. Natl. Acad. Sci. U. S. A. 78 1981 6181 6185 (Pubitemid 12174847)
92. J. Xu, M. Xu, Y.L. Hurd, G.W. Pasternak, and Y.X. Pan Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene J. Neurochem. 108 2009 962 972
93. J. Xu, M. Xu, G.C. Rossi, G.W. Pasternak, and Y.X. Pan Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1 Mol. Pain 7 2011 9
94. A. Zimprich, B. Bacher, and V. Höllt Cloning and expression of an isoform of the rmu-opioid receptor (rmuOR1B) Regul. Pept. 54 1994 347 348 (Pubitemid 24360472)